In this report, we provide an overview of the data reported by countries in the EU and EEA in 2023 to describe progress towards the 2025 interim targets for hepatitis elimination as outlined in the WHO European Region Action Plan 2022–2030.
In 2022, 23 273 cases of hepatitis C were reported in 29 EU/EEA countries. Excluding countries that only reported acute cases, 23 249 cases were notified, corresponding to a crude rate of 6.2 cases per 100 000 population.
Recent ECDC data show that despite progress in prevention and control efforts, the hepatitis B and hepatitis C viruses (HBV and HCV) continue to pose significant public health challenges in the European Union and European Economic Area (EU/EEA).
The annual European Scientific Conference on Applied Infectious Disease Epidemiology (ESCAIDE) is taking place in Stockholm and online from 20-22 November 2024.
As the summer season is approaching, ECDC is hosting an online scientific seminar to raise awareness of vibriosis and it associated risks. The main target audience is the European Food- and Waterborne Diseases and Zoonoses Network but registration is open for anyone with an interest in the topic.